The Limbic

EAN 2020: Bruton kinase inhibitors show promise in MS

Treatment of relapsing remitting MS with BTK inhibition appears to be well tolerated and effective on MRI, the European Association of Neurology (EAN) 2020 Virtual Congress was told. Professor Daniel Reich, from the US National Institute of Neurological Disorders and...

Treatment of relapsing remitting MS with BTK inhibition appears to be well tolerated and effective on MRI, the European...

Epilepsy

Still too many preventable epilepsy deaths

Mortality has not improved in epilepsy over time despite advances in medical care and despite evidence that many of the deaths are potentially preventable. The Scottish Epilepsy Deaths Study, presented at the EAN 2020 Virtual Congress, included 2,149 epilepsy-related deaths in...

Mortality has not improved in epilepsy over time despite advances in medical care and despite evidence that many of the...

Stroke

Minor stroke: bridging therapy benefits vary with occlusion site

Bridging therapy - IV thrombolysis and additional mechanical thrombectomy - is not beneficial for all patients with minor strokes and large vessel occlusion compared to thrombolysis alone, according to a retrospective French study. The study, presented online at the EAN 2020...

Bridging therapy - IV thrombolysis and additional mechanical thrombectomy - is not beneficial for all patients with minor strokes and...